Community-acquired meticillin-resistant Staphylococcus aureus in Palestine by Kaibni, Maha H. et al.
See	discussions,	stats,	and	author	profiles	for	this	publication	at:	https://www.researchgate.net/publication/24280588
Community-acquired	meticillin-resistant
Staphylococcus	aureus	in	Palestine
Article		in		Journal	of	Medical	Microbiology	·	June	2009
DOI:	10.1099/jmm.0.007617-0	·	Source:	PubMed
CITATIONS
5
READS
7
4	authors,	including:
Mohammad	Farraj
Birzeit	University
22	PUBLICATIONS			143	CITATIONS			
SEE	PROFILE
Kamel	M	Adwan
An-Najah	National	University
57	PUBLICATIONS			610	CITATIONS			
SEE	PROFILE
Tamer	Essawi
Birzeit	University
26	PUBLICATIONS			741	CITATIONS			
SEE	PROFILE
All	in-text	references	underlined	in	blue	are	linked	to	publications	on	ResearchGate,
letting	you	access	and	read	them	immediately.
Available	from:	Tamer	Essawi
Retrieved	on:	15	August	2016
Downloaded from www.microbiologyresearch.org by
IP:  46.246.28.95
On: Tue, 27 Oct 2015 20:54:40
Community-acquired meticillin-resistant
Staphylococcus aureus in Palestine
Maha H. Kaibni,1 Mohammad A. Farraj,1 Kamel Adwan2
and Tamer A. Essawi1
Correspondence
Tamer A. Essawi
tessawi@birzeit.edu
1Master Program in Clinical Laboratory Science (MCLS), Birzeit University, Birzeit, Palestine
2Department of Biology and Biotechnology, An-Najah N. University, Nablus, Palestine
Received 28 October 2008
Accepted 3 February 2009
Community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA) is becoming an
important public-health problem. This study attempted to investigate S. aureus and MRSA
colonization in nasal swabs obtained from 843 patients without a history of hospitalization at the
time of hospital admission and from 72 health-care workers chosen for comparison. Of the
patients, S. aureus was detected in 218/843 (25.9%) and MRSA in 17/843 (2.0%). Of the
health-care workers, S. aureus was detected in 15/72 (20.8%) and MRSA in 10/72 (13.9%).
The majority of the 27 MRSA isolates exhibited a sensitivity pattern expected for CA-MRSA.
Multilocus restriction fragment typing resolved the isolates into eight restriction fragment types.
The predominant restriction fragment types were AAACCAA and AAAAAAA, accounting for
51.9% (14/27) of the MRSA isolates and included CC5 and CC1 groups, respectively. This
study thus demonstrated the transmission of CA-MRSA strain types into a health-care setting,
emphasizing the need for implementation of a revised set of control measures in both hospital and
community settings.
INTRODUCTION
Hospitals worldwide are increasingly concerned with
infection by meticillin-resistant Staphylococcus aureus
(MRSA). Whereas hospital-acquired MRSA has been a
concern for in-patients since the 1960s, the threat of
community-acquired MRSA (CA-MRSA) has recently been
associated with healthy people without traditional risk
factors (Carleton et al., 2004; Seybold et al., 2006; Zetola
et al., 2005).
Strains of CA-MRSA are more frequently susceptible to a
variety of non-b-lactam antibiotics. Although a small
percentage contain SCCmec type V, these strains predo-
minantly carry SCCmec type IV, which is smaller in size
than the gene cassette found in most strains of hospital-
acquired MRSA (types I, II and III). This observed
differential in SCC size may allow more efficient transfer
of resistance among different bacteria (Albrich & Harbarth,
2008; Boyle-Vavra et al., 2005; Carleton et al., 2004; File,
2007; Oliveira et al., 2006; Weber, 2005; Zetola et al., 2005).
Several reports have described the entry of CA-MRSA
strain types into health-care settings (Albrich & Harbarth,
2008; Carleton et al., 2004; File, 2007; Klevens et al., 2006;
Zetola et al., 2005). No articles have documented CA-
MRSA emergence in Palestine. The objectives of this
investigation were to describe trends in S. aureus and
MRSA infections in Palestine, to explore the transmission
of these strains into health-care settings and to characterize
the CA-MRSA strains circulating in Palestine.
METHODS
Clinical specimens. This study was conducted over a period of
1 year (2003) to determine the carriage rate and characteristics of CA-
MRSA in patients admitted to Ramallah Governmental Hospital,
Palestine. Ramallah Governmental Hospital is the biggest hospital in
the West Bank. It is located in the city of Ramallah and serves 16
municipalities, 53 villages and five refugee camps. A total of 843 nasal
swabs were obtained from patients who had no contact with health-
care workers at the time of hospital admission and analysed for the
presence of S. aureus. For the purpose of comparing the carriage ratio
of S. aureus in the study group, 72 volunteer health-care workers
working in close contact with patients in the Internal Medicine Wards
were also included in this study. S. aureus isolates were defined as
catalase-producing Gram-positive cocci that were positive for
coagulase activity.
Antimicrobial susceptibility testing. All S. aureus isolates were
tested for meticillin resistance. The disc-diffusion method outlined by
the National Committee for Clinical Laboratory Standards (NCCLS,
1990) was used with a 1 mg oxacillin disc (Oxoid). Zone sizes were
read after incubation at 35 uC for 24 h. Isolates with zone sizes
¡10 mm were considered to be meticillin resistant. Isolates giving a
zone of ¡10 mm were confirmed as meticillin resistant by the
ability of the isolates to grow on Mueller–Hinton agar (Oxoid)
Abbreviations: CA-MRSA, community-acquired meticillin-resistant
Staphylococcus aureus; MLRFT, multilocus restriction fragment typing;
RFT, restriction fragment type.
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supplemented with 4% sodium chloride and 4 mg oxacillin l21
(McDougal & Thornsberry, 1986). Genetic resistance to meticillin was
verified by detection of the mecA gene (Predari et al., 1991). A
standard strain of S. aureus (ATCC 25923) was used as a control.
Meticillin-resistant isolates were tested against other antibiotics using
the disc-diffusion method (NCCLS, 1990).
Multilocus restriction fragment typing (MLRFT). MLRFT was
performed as described previously (Diep et al., 2003).
DNA extraction. DNA was isolated as described previously (Unal et
al., 1992). One loopful of S. aureus cells was harvested from agar
plates. Cells were resuspended in 50 ml lysostaphin (Sigma Chemical)
at 100 mg ml21 and incubated for 10 min at 37 uC. Proteinase K at a
concentration of 100 mg ml21 and 150 ml 0.1 M Tris/HCl (pH 7.5)
were then added, followed by incubation for 10 min at 37 uC and for
5 min at 95 uC. The cell debris was pelleted by centrifugation at
8000 g for 5 min and the supernatant containing the released DNA
was transferred to a fresh microcentrifuge tube. PCR amplification
was performed in a 50 ml reaction volume containing 4 ml of the
boiled whole-cell lysate, 1 mM each forward and reverse primer,
0.2 mM each dNTP, 1.25 U Taq DNA polymerase and 5 ml 106
buffer B with 1.5 mM MgCl2 supplied with the polymerase (MBI
Fermentas). Seven housekeeping genes were amplified in PCRs using
primers and PCR cycling conditions described previously for MLRFT
(Enright et al., 2000). Amplicons were subjected directly to digestion
with restriction endonucleases by adding 10 ml DNA amplicon to
20 ml of a reaction mixture containing 3 ml 106 digestion buffer and
5 U restriction enzyme. Complete digestion was achieved without
prior purification of the PCR amplicon. The restriction enzymes used
alone or in combination for each locus were HinfI, AluI, Tsp509I,
CfoI, RsaI, BbuI, MboI, VspI and DdeI. CfoI and DdeI were purchased
from Roche and the other restriction enzymes were purchased from
MBI Fermentas.
Restriction fragments were electrophoresed on 4.0% agarose gels
(Sigma) stained with ethidium bromide alongside a 50 bp DNA
ladder (Roche). The gels were visualized on a UV transilluminator
and photographed.
Restriction fragment types (RFTs) were defined by the combination
of alleles at the seven loci in the order arcC–aroE–glpF–gmk–pta–tpi–
yqiL (e.g. RFT-BBBBBAB).
RESULTS
Bacteriological screening
A total of 218 (25.9%) S. aureus isolates from 843 nasal
samples were obtained from patients at the time of hospital
admission during the study period. MRSA was detected in
17 samples (2.0%). S. aureus was identified in 15/72
(20.8%) nasal swabs of health-care workers and MRSA was
isolated in 10/72 (13.9%).
The 27 MRSA isolates in our sample population had a broad
range of antibiotic-resistance patterns (Table 1). All isolates
were fully resistant to ampicillin. Rates of resistance to non-
b-lactam antibiotics were 29.6% to ciprofloxacin (eight
isolates), 18.5% to erythromycin (five isolates), 11.1% to
clindamycin (three isolates) and 7.4% to tetracycline (two
isolates). No vancomycin-resistant isolates were identified.
Analysis of the 27 MRSA isolates revealed eight RFTs by
MLRFT. The predominant RFTs, AAACCAA and
AAAAAAA, were represented by eight (29.6%) and six
(22.2%) of the isolates, respectively. Other less-frequent
MRSA RFTs were CAAACAC and AAABCBC (four isolates
each), AAJBCBC (two isolates), and AAAACAA, BBBBBAB
and BAAACAC (one isolate each) (Table 2). Because of the
translational property between MLRFT and multilocus
sequence typing, the common MRSA RFTs could pro-
visionally be identified as belonging to sequence types
corresponding to known MRSA clonal lineages: RFT-
AAACCAA to the new CC5 strain and AAAAAAA to the
CC1 group (Enright et al., 2002).
Interestingly, 17 (63.0%) of the isolates were noted to be
susceptible to non-b-lactam antibiotics such as ciproflox-
acin, erythromycin, tetracycline and clindamycin. These
isolates were detected in six RFT groups. It is noteworthy
that, among these six RFT groups, four groups,
AAACCAA, AAAAAAA, AAABCBC and AAJBCBC, were
found to be circulating in both community and health-care
settings.
In the present study, three of the eight isolates in the
common RFT-AAACCAA group were resistant to cipro-
floxacin, a much higher proportion than that found in any
of the other RFT groups containing MRSA isolates.
Furthermore, these MRSA strains exhibited resistance to
only a few antibiotics (to erythromycin in three of the eight
isolates and to clindamycin in two of the eight isolates);
this was in contrast to the typical pattern of resistance seen
in the second most common group, RFT-AAAAAAA. The
RFT-AAAAAAA isolates were fully susceptible to cipro-
floxacin, erythromycin, tetracycline and clindamycin.
DISCUSSION
CA-MRSA infections are becoming more widely reported,
although the prevalence of MRSA carriage overall remains
low in healthy persons in the community (Harbarth et al.,
2005; Salgado et al., 2003).
In our study, the rate of colonization of S. aureus among
healthy patients at the time of hospital admission was
Table 1. Patterns of resistance to individual antibiotics among
27 MRSA isolates
Resistance pattern* Resistance profile No. of isolates (%)
Amp I 17 (63.0)
Amp, Cip II 4 (14.8)
Amp, Cip, Ery, Cli III 3 (11.1)
Amp, Ery IV 1 (3.6)
Amp, Cip, Ery, Tet V 1 (3.6)
Amp, Tet VI 1 (3.7)
*Amp, Ampicillin; Cip, ciprofloxacin; Ery, erythromycin; Cli,
clindamycin; Tet, tetracycline.
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25.9% and carriage of MRSA was 2.0%. Data reported in
other studies worldwide show a similar incidence among
healthy persons in the community (Salgado et al., 2003;
Shobha et al., 2005).
Of the 72 health-care workers screened, S. aureus was
detected in 20.8% and MRSA was detected in 13.9%. The
prevalence of S. aureus carriage was within the range
reported previously. In 41 studies, the mean carriage of S.
aureus was 23.7% [2508/10 589 health-care workers; range
0–40%, 95% confidence interval (CI) 10.7–36.7%]
(Albrich & Harbarth, 2008; Shobha et al., 2005; Dimitrov
et al., 2003). Although the small number of tested samples
limits generalizations, MRSA carriage in the health-care
workers in this study was relatively high compared with
that reported in many other countries. In 127 studies, the
mean prevalence of MRSA was 4.6% (1545/33 318 HCW;
range 0–59%, 95% CI 1.0–8.2%) (Albrich & Harbarth,
2008; Dimitrov et al., 2003; Rioux et al., 2007; Shobha et
al., 2005).
Analysis of the 27 MRSA isolates by MLRFT placed the
isolates into eight RFTs with worldwide distribution as
described previously by others (Diep et al., 2003; Vivoni et
al., 2006), showing that these RFTs have the ability to
spread to distant areas.
The majority of the 27 MRSA isolates exhibited sensitivity
patterns expected for CA-MRSA, i.e. typically less resistant
to non-b-lactam antimicrobial agents such as clindamycin,
erythromycin, ciprofloxacin and tetracycline (Table 1), a
finding that has been mirrored elsewhere (Albrich &
Harbarth, 2008; Carleton et al., 2004; File, 2007; Zetola
et al., 2005).
This was a cross-sectional study with a relatively small
sample size. Additionally, staphylococcal chromosomal
cassette mec (SCCmec) typing was not performed.
However, according to the high correlation between the
genotype and antibiogram, we could assume that at least
some of these MRSA strains had SCCmec type IV/V.
SCCmec type IV/V has increased mobility and therefore
greater potential for horizontal spread to diverse S. aureus
genetic backgrounds compared with other SCCmec types
(Albrich & Harbarth, 2008; Carleton et al., 2004; File, 2007;
Ito et al., 2001; Robinson & Enright, 2003; Zetola et al.,
2005).
The emergence of CA-MRSA and the growing presence of a
community reservoir for meticillin-resistant strains
threaten the future control of antimicrobial resistance in
the health-care setting; it is possible that they may develop
additional antimicrobial resistance (Klevens et al., 2006;
Seybold et al., 2006). This phenomenon could be explained
by the presence of some CA-MRSA RFTs within health-
care settings such as AAAAAAA (six isolates), AAAACAA
(one isolate), AAABCBC (four isolates), AAACCAA (three
isolates), AAJBCBC (two isolates) and BBBBBAB (one
isolate), defined by MLRFT analysis, which together
accounted for 63.0% of the isolates (Table 2).
In conclusion, this study has described the emergence of
CA-MRSA in Palestine. In addition, similar to the situation
that is occurring in other countries, we demonstrated CA-
MRSA strain type transmission within a health-care setting,
a finding that emphasizes the need for implementation of a
revised set of control measures in both hospital and
community settings.
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